Literature DB >> 9123878

Isolation and characterization of vesicular stomatitis virus PoIR revertants: polymerase readthrough of the leader-N gene junction is linked to an ATP-dependent function.

J L Chuang1, R L Jackson, J Perrault.   

Abstract

The switch from transcription to replication of the VSV genome is coupled to assembly of nascent chains and involves an unspecified change in the P-L polymerase complex when it reaches the leader-N gene junction. PoIR VSV mutants, in contrast to wild-type virus, read through this first gene junction at high frequency without concurrent assembly, and they show altered ATP requirements for transcription in vitro. The mutation(s) responsible for the poIR phenotype segregates to the N-RNA template fraction. We report here that both poIR1 and poIR2 mutants display severe growth restriction in mouse L cells but not in BHK cells. Four of six poIR1 revertant viruses, originating from rare plaques on L cells, showed wild-type characteristics for growth, readthrough of leader-N gene junction, and ATP utilization, while two showed partial and quantitatively parallel coreversion of all properties. Sequence analysis of N and P genes of poIR mutants and revertants provided proof that a single mutation in the N protein, Arg179 to His, is responsible for the poIR phenotype. PoIR1, but not poIR2, also displayed a phenotypically silent GA-to-GG change in the N-P intergenic dinucleotide sequence Five of six revertants retained the poIR1 N protein mutation and showed no change in their P gene. We conclude that the L protein likely contains second-site suppressors of the poIR phenotype, and we propose that the switch from transcription to replication is modulated by an ATP-dependent interaction between the template-associated N protein and the L subunit of the P L polymerase complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9123878     DOI: 10.1006/viro.1996.8418

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  "Rule of six": how does the Sendai virus RNA polymerase keep count?

Authors:  D Vulliémoz; L Roux
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 2.  Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited.

Authors:  D Kolakofsky; T Pelet; D Garcin; S Hausmann; J Curran; L Roux
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Cell-type-specific growth restriction of vesicular stomatitis virus polR mutants is linked to defective viral polymerase function.

Authors:  Derek Ostertag; Traci M Hoblitzell-Ostertag; Jacques Perrault
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

4.  Overproduction of double-stranded RNA in vesicular stomatitis virus-infected cells activates a constitutive cell-type-specific antiviral response.

Authors:  Derek Ostertag; Traci M Hoblitzell-Ostertag; Jacques Perrault
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

5.  Functional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus.

Authors:  R Fearns; P L Collins; M E Peeples
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Single-amino-acid alterations in a highly conserved central region of vesicular stomatitis virus N protein differentially affect the viral nucleocapsid template functions.

Authors:  Debasis Nayak; Debasis Panda; Subash C Das; Ming Luo; Asit K Pattnaik
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

7.  A bioinformatics approach to the structure, function, and evolution of the nucleoprotein of the order mononegavirales.

Authors:  Sean B Cleveland; John Davies; Marcella A McClure
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

Review 8.  Animal and human RNA viruses: genetic variability and ability to overcome vaccines.

Authors:  T G Villa; Ana G Abril; S Sánchez; T de Miguel; A Sánchez-Pérez
Journal:  Arch Microbiol       Date:  2020-09-28       Impact factor: 2.552

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.